Dr. Lynch most recently served as chief scientific officer at New York City-based pharmaceutical manufacturer Bristol-Myers Squibb.
While at Bristol-Myers Squibb, he focused on cancer, cardiovascular disease, fibrosis and immunoscience research and development efforts, including translational immuno-oncology research, according to a news release.
Dr. Lynch’s previous positions include chairman and CEO of Massachusetts General Physicians Organization, a multispecialty medical group; director of Yale Cancer Center; physician-in-chief of Yale’s Smilow Cancer Hospital in New Haven, Conn.; professor of medicine at Yale School of Medicine; chief of hematology-oncology at Boston-based Massachusetts General Hospital; and professor of medicine at Harvard Medical School.
More articles on executive moves:
AdventHealth taps Justin Birmele to helm Winter Park hospital
Cape Fear Valley Health System CEO Mike Nagowski returns from medical leave
Joseph Mullany named president of Vassar Brothers Medical Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
